Comparison of the applicability of Hasford score and European Treatment and Outcome Study score in Indian patients with chronic phase chronic myeloid leukemia on imatinib therapy
Main Authors: | Neha Chopra Narang, Mrinalini Kotru, Meera Sikka, Usha Rusia |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2017-01-01
|
Series: | South Asian Journal of Cancer |
Online Access: | http://journal.sajc.org/article.asp?issn=2278-330X;year=2017;volume=6;issue=3;spage=117;epage=138;aulast=Narang |
Similar Items
-
Morphological Changes in Bone Marrow Post Imatinib Therapy in Chronic Phase CML: A Follow up Study on Sequential Bone Marrow Aspirates and Biopsies
by: Neha Chopra Narang, et al.
Published: (2017-04-01) -
Comparison of the utility and applicability of the Sokal, Hasford, and EUTOS scores in a population of Chinese patients with chronic-phase chronic myeloid leukemia undergoing imatinib therapy
by: Xia L, et al.
Published: (2015-09-01) -
Association between Hasford Scoring System and Hematologic Response in Chronic and Accelerated Phase of Chronic Myelocytic Leukemia Patient with Imatinib for Three Months
by: Andy Purnomo, et al.
Published: (2019-09-01) -
Comparison of Socal Score and Hasford Score Against the Response of Imatinib Mesylate Therapy in Patients with Chronic Granulocytic Leukemia in dr. Saiful Anwar Hospital Malang
by: Somarnam, et al.
Published: (2019-12-01) -
The Hasford Score May Predict Molecular Response in Chronic Myeloid Leukemia Patients: A Single Institution Experience
by: Jarosław Dybko, et al.
Published: (2016-01-01)